Quest Diagnostics | LinkedIn (original) (raw)
``
Medical and Diagnostic Laboratories
Secaucus, NJ 311,054 followers
Working together to create a healthier world, one life at a time.
About us
Quest Diagnostics (NYSE: DGX) empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. The company offers physicians the broadest test menu (3,000+ tests), is a pioneer in developing innovative new tests, is the leader in cancer diagnostics, provides anatomic pathology (AP) services, & interpretive consultation through its medical & scientific staff of about 900 M.D.s & Ph.D.s. The company reported 2020 revenues of $9.44 billion. Quest Diagnostics offers the most extensive clinical testing network in the U.S., with laboratories in most major metropolitan areas, & in Mexico, the UK & India. The company also operates four esoteric laboratories, 40 outpatient AP laboratories, & 160 smaller, rapid-response laboratories. Patients may have specimens collected in any of the company’s approximately 2,250 patient service centers. On a typical workday, testing is performed for about 550,000 patients. Quest Diagnostics empowers healthcare organizations & clinicians with state-of-the-art connectivity solutions. The company is the leading provider of pre-employment drugs-of-abuse screening for employers & risk assessment services for the life insurance industry. It is the world’s 2nd largest provider of clinical trials testing for new pharmaceuticals. More information is available at www.questdiagnostics.com. Language Assistance / Non-Discrimination Notice Asistencia de Idiomas / Aviso de no Discriminación 語言協助 / 不歧視通知 www.QuestDiagnostics.com/home/nondiscrimination
Industry
Medical and Diagnostic Laboratories
Company size
10,001+ employees
Headquarters
Secaucus, NJ
Type
Public Company
Founded
1967
Specialties
Diagnostic testing information and services, Clinical testing, cancer diagnostics and anatomic pathology services, Gene-based and other esoteric testing, and Healthcare information technology solutions
Products
Quanum Practice Management
Medical Practice Management Software
Increase the efficiency of your practice with Quanum™ Practice Management. Manage patient appointments, billing & more. Get info today!
Locations
Employees at Quest Diagnostics
Updates
- Congratulations to LifeLabs Medical Laboratory Services on being recognized as the Most Trusted Health Diagnostic Service Provider in Canada for the third year in a row!
Exciting news! LifeLabs has been recognized as Canada’s Most Trusted Health Diagnostic Service provider for the *third consecutive year*! Thank you, BrandSpark® Most Trusted Awards, for this recognition! This win reflects the hard work and dedication of our entire team, especially our frontline staff who bring compassion and excellence to our customers every day. Thank you to our entire LifeLabs team for their hard work and to our customers for their trust and support! Full details: https://lnkd.in/gkwxxdU5 - “Life’s Most Persistent and Urgent Question Is, “What Are You Doing for Others?” – Martin Luther King Jr. In honor of Martin Luther King Jr. and on National Day of Service, we’d like to thank our African-American Business Leaders (ABL) Network and Inclusion & Diversity team for helping our colleagues find opportunities to volunteer and give back to our communities. Join us in our efforts to create a more just and equitable society, which is core to our work in healthcare and to our culture at Quest.#QuestDiagnostics #MLKDay #DayofService #InclusionandDiversity
- On December 9, Quest launched NPS 2.0, the next generation for detection of novel psychoactive substances. The newly updated panel includes more than 25 additional analytes (vs the prior version) and can be ordered using the same test code, 13086. It draws on our extensive internal surveillance as well as the latest input from published research, law enforcement, and public health agencies to help keep your screening and monitoring up-to-date on the newest generations of designer drugs. To learn more about the full range of Quest Diagnostics resources for drug screening and identification, visit http://spr.ly/6048vNGju.
- Get the latest insights about the use of NPS from our nationwide analyses of drug testing samples in this on-demand webinar. Dr Jack Kain and Jason Suomala from the Quest Drug Monitoring & Toxicology team share learnings from our ongoing identification and tracking of the emerging generation of NPS, including the results of in-depth HPLC/MS analyses of thousands of drug screening samples. Quest is working to help you address the growing use of NPS and the challenges they pose for your patient drug screening and monitoring efforts. Watch the webinar http://spr.ly/6049Q9AyL.
Join now to see what you are missing
Affiliated pages
Similar pages
Browse jobs
- Quest Diagnostics jobs 3,971 open jobs
- Director jobs 1,220,357 open jobs
- Manager jobs 1,880,925 open jobs
- Director Data Science jobs 4,457 open jobs
- Analyst jobs 694,057 open jobs
- Associate jobs 1,091,945 open jobs
- Vice President jobs 235,270 open jobs
- Phlebotomist jobs 64,786 open jobs
- Specialist jobs 768,666 open jobs
- Laboratory Scientist jobs 17,850 open jobs
- Scientist jobs 48,969 open jobs
- Senior Director jobs 117,535 open jobs
- Executive Director jobs 59,502 open jobs
- Director of Business Development jobs 28,621 open jobs
- Account Manager jobs 121,519 open jobs
- Medical Laboratory Scientist jobs 16,961 open jobs
- Director of Operations jobs 61,881 open jobs
- Human Resources Business Partner jobs 19,788 open jobs
- Associate Director jobs 125,209 open jobs
- Healthcare Specialist jobs 33,605 open jobs
Stock
DGX
January 23, 2025
NYSE
20 minutes delay
Open
151.74
Low
151.65
High
152.38
Data from Refinitiv